 of the disease process.
These clinical practice guidelines were developed by
the committee under the guidance of the Society for
Vascular Surgery to facilitate evidence-based clinical decision making for patients with CMI. They were limited to
patients with CMI related to atherosclerotic occlusive disease. CMI was deﬁned as ischemic symptoms caused by
insufﬁcient intestinal blood ﬂow to the gastrointestinal
tract for a duration of 3 months as deﬁned by the